Winter Scientific Conference 2022
Watch the whole UK Biobank Winter Scientific Conference on demand!
The UK Biobank Winter Scientific Conference took place on Thursday the 8th of December 2022, and is now available to watch on demand. We hope you were there and enjoyed it just as much as we did. We also look forward to hearing more about novel scientific results and exciting future developments in the future as a result of use of the UK Biobank resource.
Multi-omics in UK Biobank
This session covered the potential for vast amounts of new data to be generated from UK Biobank’s biological samples. Including information about the measurement and analysis of metabolomics, proteomics, epigenetics and infectious disease markers in UK Biobank for health-related research.
Professor Valerie O’Donnell, Cardiff University: Session Chair
Dr Chris Whelan, Janssen: The story so far – the UK Biobank Pharma Proteomics Project
Heli Julkunen, Senior Data Scientist, Nightingale Health: The value of metabolomics data in UK Biobank
Professor Wolf Reik, Altos: Epigenetic assay strategies
Dr Charlotte Warren-Gash, LSHTM: Measuring infectious markers in UK Biobank and its potential value
Panel Discussion
How UK Biobank is enabling dementia research
The first of our afternoon sessions explored how UK Biobank is enabling dementia research, and provided insights into how repeat imaging and digital tools could be used to better characterise cognitive decline and disease classification.
Professor Julie Williams, UK DRI: Session Chair
Professor Paul Matthews, Imperial College London: Added value of repeat imaging and assays
Professor David Llewellyn, Exeter University: Multimorbidity and dementia risk
Professor James Rowe, University of Cambridge: Prediagnostic supranuclear palsy
Professor Valentina Escott-Price, Cardiff University: The use of genetic risk scores to stratify populations for dementia risk
Panel discussion
Enhanced health outcomes data in UK Biobank
Our final session covered UK Biobank's strategy for incorporating new data on health outcomes into the resource. This includes linkage to cancer histopathology datasets, and ophthalmic healthcare records. The session also covered approaches needed to characterise health outcomes at-scale across diverse health record data.
Professor John Danesh, Cambridge University: Session chair
Professor Naomi Allen, UK Biobank: UK Biobank's strategy for phenotyping health outcomes
Professor Josh Denny, NIH: Use of automated approaches for outcome phenotyping using existing linkages
Kezia Gaitskell, University of Oxford: Value of digital histopathology slides for phenotyping cancer outcomes
Anthony Khawaja, University College London: Value of linking to ophthalmic healthcare records
Panel discussion
Last updated